Investigational Site Number : 4840005

Mexico City 14050

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer Metastatic, Primary Progressive Multiple Sclerosis

Studies at this site

• Phase 2 Study of Amcenestrant (SAR439859) Versus Physician's Choice in Locally Advanced or Metastatic ER-positive Breast Cancer — Stopped early
• Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) — Completed